Home Top Movers Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on June 11, 2021, after which the MBIO stock price saw a push of 5.25% to reach $4.01 a share at the time of this writing. The last trading session was favorable for MBIO stock as it went up by 1.33% at closing. Let’s deep dive to explore more of it.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What’s Happening?

The hype was noticed today in the previously rising MBIO stock price after the release of interim data taken from the clinical trial of  MB-106 CD20-targeted, autologous CAR T in order to investigate the safety and accuracy of cell therapy which is intended for the treatment of patients suffering from Relapsed or Refractory B-cell Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia. Mustang and Fred Hutchinson Cancer Research Center are both collaborating with each other in the development of MB-106. In the treatment of 15 patients, the overall response rate was 93% and the complete response rate was 67% representing a very favorable safety and efficacy profile of MB-106

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Previous Activity by MBIO stock:

Back to the previous month on May 18, 2021, MBIO stock did announce that it has dosed the first patient in the clinical trial in order to evaluate the safety and feasibility of MB-101 in patients suffering from leptomeningeal brain tumors. This trial would comprise 30 patients and would take place at the City of Hope. In case of need, both Mustang and City of Hope would provide the facility of transferring patients to the other centers.

Financial View of MBIO stock:

  • MBIO stock reported a net loss of $15.0 million, or $0.19 per share attributable to common stockholders in the first three months of 2021 as compared to $11.9 million, or $0.28 per share net loss in the same period of the previous year.
  • Mustang stock spent $11.6 million in the research and development expenses in the recently reported quarter while these expenses were $9.6 million in the same tenure of the prior year.
  • MBIO’s general and administrative expenses increased to $3.5 million in the first quarter of 2021 from $2.0 million in the same quarter of the previous year.
  • MBIO stock had cash and cash equivalents and restricted cash of $130.4 million by the end of March 2021 which is significantly higher than $98.8 million by the end of December 2020.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Wrap Up:

So far so good for Mustang stock as far as market sentiment is concerned. The recent clinical trial results for MB-106 were favorable for MBIO stock and it seems that Mustang is continuously putting its effort into the development of cell and gene therapies. But how good this stock is for investors, deep fundamental as well technical analysis is necessary to answer this question.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Here’s why Soligenix, Inc. (SNGX) stock is Popping High today

Soligenix, Inc. (SNGX) stock gained Pediatric Investigation Plan (PIP) waiver for HyBryte™ (SGX301 or hypericin) by European Medicines Agency (EMA) after which the SNGX...

Clover Health Investments Corp. (CLOV) stock rises during pre-market. Let’s find out why?

Clover Health Investments Corp. (NASDAQ: CLOV) stock declined by 23.61% at last close while the CLOV stock price gains by 5.73% in the pre-market...

GameStop Inc. (GME) stock plunged during after-hour session. Here’s the update

GameStop Inc. (NASDAQ: GME) stock gained by 0.85% at the last close while the GME stock price declines by 5.21% in the after-hours session....

CynergisTek, Inc. (CTEK) Stock Surges Following Granting of C3PAO Accreditation

CynergisTek, Inc. (CTEK) stock prices were up by a significant 32.26% shortly after market trading commenced on June 9th, 2021, bringing the price per...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam